论文部分内容阅读
Circulating HER2 extracellular domain (ECD) predicts a poor prognosis for metastatic breast cancer p
【机 构】
：
Zhejiang Cancer Research Institute, Zhejiang Cancer Hospital, No.38 Guangji Rd., Banshan-qiao Distri
【出 处】
：
第五届浙江省胸部肿瘤论坛暨长三角专家峰会
【发表日期】
：
2012年4期
其他文献
[背景与目的]随着高效低度药物的出现越来越多的晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)患者有机会接受三线治疗,但目前三线的标准治疗除厄洛替尼外尚无其它选择方案.本研究旨在比较单药化疗、靶向药物与双药联合化疗在晚期NSCLC患者三线治疗中的疗效与安全性。 [方法]回顾分析115例Ⅲb期/Ⅳ期接受三线治疗的NSCLC患者的疗效及生存状况。采用Kaplan-
[目的]比较复治晚期非小细胞肺癌(non-small cell lung cancer，NSCLC)表皮生长因子受体-酪氨酸激酶抑制剂(epidermal growth factor receptor-tyrosine kinase inhibitor，EGFR—TKI)治疗失败后用培美曲塞与多西他赛挽救性化疗疗效及毒副反应。 [方法]回顾性分析我院120例复治晚期NSCLC患者。EGFR—TK
肺癌是严重威胁人民健康的重大疾病之一，由于缺乏可靠的早期诊断方法及有效的晚期治疗手段，自1970年至今其生存率一直没有较大的提高，长期居于癌症死亡病因的首位。而对于有可靠的早期筛查方法的乳腺癌、结肠癌及前列腺癌来说，其5年生存率可达肺癌的4-6倍。所以，探索肺癌的早期诊断方法具有至关重要的意义。而肺癌的肿瘤标志物研究以其无创、可重复性强等特点，在科研及临床上具有着独特的优势。本文旨在对肺癌相关肿瘤
[目的]分析索拉非尼联合经导管肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)治疗肝细胞癌(hepatocelllular carcinoma,HCC)多发肺转移的疗效. [方法]15例伴有多发肺转移的晚期HCC患者,肝脏原发肿瘤经导管肝动脉化疗栓塞(transcatheter-arterial chemoembolization,TA
BACKGROUND: Prophylactic cranial irradiation (PCI) has been considered standard treatment in patients with limited-stage small cell lung cancer(LS-SCLC) in complete remission following systemic therap
[Introduction] This study aims to compare treatment outcomes between stereotactic body radiation therapy (SBRT) and surgery in early-stage non-small-cell lung cancer (NSCLC). [Methods] Eligible studie
会议
Adenovirus-mediated interferon -7 gene therapy efficiently induced human pancreatic carcinoma Capan-
Background:Pancreatic cancer survival continues to be amongst the shortest of all cancers, and new therapies are urgently needed. In this study, we sought to identify the potential therapeutic effects
胃癌是严重危害人类健康的常见恶性肿瘤之一。在胃癌中,ErbB2致癌基因的扩增或过度表达是导致其不良预后的一个独立的影响因素。人表皮生长因子受体2 (human epidermal growth factor re-ceptor 2,HER-2/neu)基因是一种原癌基因。体内外研究证实HER-2癌基因也是肿瘤转移驱动因子,即HER-2过度表达的恶性肿瘤具有更强的侵袭、转移能力,预后较差。在日本晚期
Circulating HER2 extracellular domain (ECD) levels are associated with progression -free survival in
会议
BRCA1 Germ-line Mutations and Tumor Characteristics in Eastern Chinese Women with Familial Breast Ca
Although several studies detected the BRCA1 germ-line mutations in Chinese women with familial breast cancer, most of them did not employed conventional full gene sequencing, especially in eastern Chi